An Act relative to cancer patient access to biomarker testing to provide appropriate therapy

This bill aims to improve access to biomarker testing for cancer patients in Massachusetts to help them receive the most appropriate therapy. It requires health insurers to cover the cost of these specific tests without imposing additional restrictions or requiring prior authorization beyond what is already standard for other medical services. The legislation directly affects cancer patients, their families, and health insurance providers by ensuring that necessary diagnostic tools are financially accessible. By removing barriers to testing, the bill seeks to facilitate better treatment decisions based on individual patient biology.